TCTR20220725001Unknown1 期
Intralymphatic immunotherapy for house dust mite allergic rhinitis, a pilot study
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 65 Years（—）
- 性别
- All
入选标准
- •Age 20-65 years with house dust mite allergic rhinitis and/or asthma
排除标准
- •Previous AIT
- •Pregnancy/breastfeeding
- •Comorbidities: Uncontrolled cardiovascular disease, uncontrolled asthma, severe renal impairment, active liver disease, malignancy, autoimmune disease
- •Idiopathic anaphylaxis
研究者
相似试验
已完成
不适用
Sublingual immunotherapy for housedust miteRespiratory: Housedust allergyRespiratoryHousedust allergyISRCTN96862420Record provided by the NHS Trusts Clinical Trials Register - Department of Health (UK)80
招募中
不适用
Sublingual immunotherapy with house dust mite allergen in children with allergic rhinitis: randomised double-blind placebo-controlled trial.allergic rhinitis related to house dust mite allergyNL-OMON28314ARTU Biologicals Europe BV256
已完成
不适用
Sublingual immunotherapy with house dust mite allergen in children with allergic rhinitis: randomised double-blind placebo-controlled trialRhinitis, allergy, house dust miteRespiratoryVasomotor and allergic rhinitisISRCTN91141483Artu Biologicals Europe B.V. (Netherlands)251
进行中（未招募）
1 期
Prevention of allergy development in preschool childreEUCTR2016-002844-18-ATMedical University of Vienna, Dpt. of Pediatrics
已完成
4 期
House Dust Mite SLIT in Elderly PatientsAllergic RhinitisNCT01605760Medical University of Silesia111